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Immunodominance of H60 Is Caused by an Abnormally
High Precursor T Cell Pool Directed against
Its Unique Minor Histocompatibility Antigen Peptide
confronted with thousands of novel MHC-presented
peptides resulting in the activation and expansion of a
large number of clonally diverse CD8 T cells (Martin and
Dyer, 1993; Pimsler and Forman, 1978). In contrast, the
recipient of MHC-matched but minor H antigen-dispa-
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Immunodominance is a poorly understood property
that allows immune responses to certain peptide epi-
topes to prevail over others. Proposed mechanisms forSummary
this phenomenon can be lumped into two categories.
The first is properties inherent to the peptide and itsThe H60 minor histocompatibility (H) antigen peptide
precursor protein such as selective peptide processing,is derived from a glycoprotein that serves as a ligand
peptide binding avidity to MHC proteins, and/or highfor the stimulatory NKG2D receptor. We show that
peptide/MHC number on antigen-presenting cellsthis peptide is remarkably immunodominant in that it
(APCs). The second is T cell based, and includes elusivecompetes effectively with MHC alloantigens, is effi-
qualitative and quantitative differences in the antigen-ciently crosspresented by host antigen-presenting
specific T cell repertoires (Chen et al., 2000; Yewdellcells (APCs), and readily elicits naive CD8 T cell re-
and Bennink, 1999). Regardless of the “upstream”sponses in vitro. H60 immunodominance is neither a
mechanisms involved, the expression of the immuno-consequence of NKG2D engagement nor competition
dominance phenotype requires successful access toamong minor H antigens on APCs. Instead, H60 immu-
antigen and costimulation on APCs, and many studiesnodominance is a consequence of an abnormally high
have reported that successful competition for antigennaive precursor frequency of H60 peptide reactive CD8
on the APC is necessary for the immunodominance traitT cells. Understanding why the H60 peptide is so im-
(Grufman et al., 1999; Kedl et al., 2000, 2002; Perreaultmunogenic has important implications in tissue trans-
et al., 1998). Overall, however, the key determinants ofplantation and vaccine design.
immunodominance remain to be firmly established.
H60 is an unusual mouse minor H antigen. While manyIntroduction
minor H antigens are alloantigenic because of discrete
amino acid changes in a core MHC-presented self-pep-
Tissues are rejected when transplanted onto genetically
tide, alloantigenicity of H60 is because responder mice,
different individuals because of allogeneic differences
such as C57BL/6 (B6), fail to express the protein from
at histocompatibility (H) antigens that evoke CD4 and which the H60 peptide derives (Malarkannan et al.,
CD8 T cell responses. Considerable effort is dedicated 1998). Moreover, the H60 glycoprotein is a member of
to matching major histocompatibility complex (MHC) the retinoic acid early inducible (Rae1) gene family.
alloantigens because they are generally considered to These genes are orthologs of the human ULBP gene
be the most significant barriers to successful trans- family and paralogs of the MHC I gene family (Cerwenka
plantation. However, despite the fact that they are et al., 2000; Diefenbach et al., 2000). Their glycoproteins
known transplantation barriers, H antigens encoded out- serve as ligands for the stimulatory natural killer (NK)
side of the MHC, the so-called minor H antigens, have receptor NKG2D and, among the mouse Rae1 family,
only recently attracted serious consideration. H60 has the highest affinity for NKG2D (Carayanno-
Both MHC class I alloantigens and minor H antigens poulos et al., 2002). NKG2D is expressed by NK cells
are comprised of self-peptide/MHC class I complexes and activated CD8 T cells (Jamieson et al., 2002), and its
arising from processed fragments of normal endoge- engagement on CD8 T cells results in signals transmitted
nous proteins loaded onto MHC class I molecules. The through the same KAP/DAP2 adaptor molecules used
former arises from natural genetic variation in the MHC for the CD28 costimulatory cascade, thus linking innate
molecule itself, resulting in a quantum change in the with adaptive immunity (Jamieson et al., 2002). Ectopic
assortment of processed self-peptides that bind each expression of H60 and the RAEs in tumor cell lines re-
MHC class I molecule. In contrast, each minor H antigen sults in rejection mediated by NK and/or CD8 T cells
is a consequence of the presentation of a genetically (Diefenbach et al., 2001), and induced expression in
variant self-peptide by an invariant MHC class I molecule carcinomas results in protection mediated by cutaneous
(Simpson and Roopenian, 1997). In a transplantation T cells expressing TCRs (Girardi et al., 2001). The CD8
setting, the recipient of MHC-disparate tissue is thus T cell response to a single H60-derived octamer peptide
(LTFNYRNL) complexed with the H-2Kb MHC class I
immunodominates over other known minor H antigens3 Correspondence: dcr@jax.org
both in spleen cell immunization protocols (Choi et al.,4 Present address: Department of Pathology, Seoul National Univer-
sity College of Medicine, Seoul 110-799 Korea. 2001) and in graft-versus-host disease (Choi et al., 2002).
Immunity
594
Remarkably, this same octamer peptide partially inhibits
NKG2D from binding the H60 glycoprotein, suggesting
that it encompasses a critical NKG2D binding site (Cer-
wenka et al., 2002). However, the relationship between
H60 as a dominant minor H antigen and H60 as a ligand
for NKG2D remains poorly understood. The goal of our
studies was therefore to thoroughly examine the phe-
nomenon of H60 immunodominance.
Results
Up to One-Half of the CD8 CTL Response Is Directed
against Immunodominant Minor H Antigens
in a Haplo-MHC Mismatched Situation
To examine whether minor H antigens are subordinate
to MHC alloantigens, C57BL/6 (B6: H-2b) female mice
were immunized, and their T cells were challenged in
mixed leukocyte culture (MLC) with MHC-matched but
background-disparate BALB.B (H-2b) or haplo-MHC-
mismatched and background-disparate (B6 x BALB/c:
H-2dxb) F1 (CB6F1) male spleen cells. To quantify the
responses to allo-MHC and minor H antigens, resting
CD8 T cells from the MLC were tested for intracellular
IFN- production after a 6 hr restimulation with CD8 T
cell-depleted stimulator spleen cells. As expected, most
(80%) of the B6 CD8 T cells primed and boosted with
BALB.B cells produced IFN- in response to H-2b-
Figure 1. Minor H Antigen Responses Compete Successfully with
restricted BALB.B-derived minor H antigens (Figure 1A). the Allogeneic MHC Response
Surprisingly, 30% of the CD8 T cells stimulated by
(A) Female B6 mice (H-2b) were immunized in vivo, and their T cells
CB6F1 male cells produced IFN- in response to H-2b- were challenged in MLC with haplo-matched CB6F1 male or BALB.B
restricted BALB.B minor H antigens (Figure 1A), while male splenocytes. Resting cells from the MLCs were restimulated
with the indicated CD8 cell-depleted stimulator splenocytes and35% and 42% of the cells produced IFN- in response
analyzed for intracellular IFN- production. BALB.B (H-2b: MHC-to BALB/c and B10.D2 alloantigens (both H-2d), respec-
matched but minor H antigen-disparate), BALB/c (H-2d: MHC- andtively (Figure 1A). To determine the cytotoxic T lympho-
minor H antigen-disparate) and B10.D2 (H-2d: MHC-disparate butcyte (CTL) specificity, cells from the MLCs were also
minor H antigen-matched) mice.
evaluated for their ability to lyse minor H antigen and (B) B6 anti-CB6F1 MLC effector cells were tested in a cell-mediated
MHC disparate target cells. A similar level of specific lympholysis (CML) assay against Con-A lymphoblasts from the indi-
cated mouse strains, including H60-congenic and H13-congeniclytic activity was detected against MHC-matched but
mice. Maximum values of % specific lysis at 25:1 effector to targetminor H-disparate BALB.B targets (48%) with MHC-dis-
cell ratio are shown.parate but background-matched B10.D2 targets and
both minor H and MHC alloantigen-disparate BALB/c
targets, 50% and 53%, respectively (Figure 1B). Since after immunization for specificity by flow cytometry us-
H60 dominates over other known minor H antigens in ing H60 peptide (H60p) tetramers. Approximately 4% of
MHC-matched spleen cell priming protocols and graft- the total blood CD8 T cells from the immunized mice
versus-host disease (Choi et al., 2002, 2001; Malarkan- stained with H60p tetramers, and all of these cells ex-
nan et al., 2000, 1998), specific lysis directed against pressed the CD11a activation marker (Figure 2A). These
H60-congenic target cells was also examined. High lev- results showed that substantial expansion of H60-spe-
els of H60-specific lysis were detected, while negligible cific CD8 T cells occurred in vivo as a consequence of
lysis was detected against H13- and HY-bearing target CB6F1 immunization.
cells (Figure 1B), even though BALB.B males are known Unexpectedly, a substantial expansion of H60p tetra-
to be disparate from B6 females at these antigens. These mer CD8 T cells (7%) was detected after immuniza-
results indicated that minor H antigens competed sur- tion with fully incompatible BALB/c splenocytes (Figure
prisingly well with MHC alloantigens when presented on 2A), but in no case did tetrameric analysis show appre-
the same APCs and that CTLs directed against H60 are ciable expansion of CD8 T cells specific for subordinate
major participants in this process. minor H antigens, H13 and HY (data not shown). The
occurrence of H60p tetramer CD8 T cells in BALB/
c-immunized mice was not a consequence of a cross-H60 Dominates In Vivo and Is Efficiently Presented
by Crosspriming reactive immune response to H-2d alloantigens, because
H60p tetramer CD8 T cells were never detected in B6To assess directly whether the CD8 T cell response
against H60 can be generated directly in vivo in the mice immunized with B10.D2 spleen cells (which are of
H-2d type and fail to express the H60 protein) (Figurepresence of an MHC disparity, female B6 mice were
immunized with CB6F1 male spleen cells, and their pe- 2A) and H60-specific CTLs failed to lyse B10.D2 target
cells (Figure 2B). Furthermore, the H60p tetramer CD8ripheral blood leukocytes (PBLs) were analyzed 7 days
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Figure 2. H60-Specific CD8 T Cells Are Readily Generated In Vivo during the Allo-MHC Response via Indirect Presentation
(A) Tetrameric analysis of PBLs from immunized B6 female mice. Pooled PBLs from five female B6 mice immunized with spleen cells from
CB6F1 male, BALB.B male, BALB/c male, or B10.D2 female mice were analyzed by flow cytometry using PE-conjugated H60p tetramers,
anti-CD8 mAb-APC, and anti-CD11a mAb-FITC 7 days after immunization. % of tetramer CD11ahigh CD8 T cells are indicated. No appreciable
tetramer staining was observed using H13p or HYp tetramers (data not shown).
(B) Anti-H60 CTLs do not recognize or crossreact with H-2d or H-2d  H60. H60p-specific CTL line, SP/H60, was tested for lytic activity against
BALB.B, B10.D2, BALB/c, H60-congenic, and syngeneic splenic lymphoblasts. HY-specific CTL line (CTL-10) known to show crossreactivity
to H-2d alloantigens was included as a positive control.
(C) B6 mice were immunized with spleen cells from CB6F1, BALB.B, or BALB/c mice, and 30 days later the immunized mice along with naive
B6 mice were grafted with skin from H60-congenic females. Ten days later, PBL CD8 T cells from the grafted mice were assessed for H60p
tetramer cells.
T cells generated in response to BALB/c cells were not response. Thirty days after female B6 mice were immu-
nized with BALB/c, CB6F1, or BALB.B splenocytes, thea consequence of CD8 T cells recognizing the native
H60 glycoprotein or H60-derived peptides bound to H-2d frequency of persisting H60p tetramer cells was
0.10.2% of the total CD8 T cell in blood (data notbecause H60-specific CTLs did not lyse BALB/c targets
(Figure 2B) nor did the cells raised by BALB.B stimula- shown). Tail skins from H60-congenic female mice were
then grafted onto these immunized mice and onto con-tion produce IFN- in response to BALB/c alloantigens
(Figure 1A). Therefore, the expansion of H60p tetramer trol naive B6 mice. On day 10 following skin grafting,
the frequency of H60p tetramer CD8 T cells in PBLsCD8 T cells in BALB/c-immunized mice is best explained
by specific T cell recognition of H60p that was efficiently had increased considerably compared with PBLs from
grafted naive controls: 3.4% in BALB.B-, 2.5% incrosspresented by B6 host APCs.
We then examined whether the H60-specific CD8 T BALB/c-, and 1.2% for CB6F1-immunized mice versus
0.1% for naive control (Figure 2C), and these frequenciescells generated while undergoing an MHC allo-response
persisted as memory cells capable of eliciting a recall paralleled the burst sizes of the primary responses (Fig-
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Figure 3. Physiological Expression of the H60 Protein Fails to Augment CTL Activation or Deliver Help
(A) H-2Db-restricted specific CTL lines for H3a, H13, and HY were tested for cytolytic activity against splenic lymphoblast targets that do
(H60-congenic female splenocytes) or do not (B6 female splenocytes) express H60 protein. The targets were loaded with varied concentrations
of cognate peptide (H3a, H13, or HY) or irrelevant peptide (F5NP).
(B) Female B6 mice were immunized with male BALB.B splenocytes (induces CD4 help) or a mixture of splenocytes from female H60-congenic
(no CD4 help) and female H13-congenic (induces CD4 help due to H3b minor H antigen) and B6 male (induces CD4 help) mice. PBLs from
the immunized mice were serially sampled for staining with H60p, H13p, and HYp tetramers.
ure 2A). These results suggested that H60-specific CD8 PBLs from B6 female mice immunized with a mixture of
splenocytes from B6 male and H13-congenic femaleT cells competed successfully with those directed
against MHC alloantigens under conditions requiring mice (both of which differ from B6 female mice by CD4
T cell stimulatory helper determinants; data not shown)indirect presentation and were fully capable of establish-
ing memory and then undergoing a recall response to and female H60-congenic mice (which lack a CD4 T cell
helper determinant; data not shown). The rationale wasH60 in the context of self-MHC (Kb) molecules.
that if the H60 glycoprotein induced costimulation/help,
it would support the generation of H60p-specific CTLsPhysiological Expression of the H60 Glycoprotein
in a CD4 help-deprived situation. However, H60p tetra-Does Not Enhance the Immunostimulatory
mer CD8 T cells were not detected in the mice immu-Capacity of pMHC Ligands
nized with this splenocyte mixture, while H13p and HYp
It has been suggested that H60 immunodominance
tetramer CD8 T cells (deliberately provided with cog-
could be a consequence of the H60 glycoprotein acting
nate CD4 T cell help) were readily detected (maximum
as an immunostimulatory ligand via its interaction with
frequency of 11.5% of total CD8 T cells on day 14;
NKG2D (Cerwenka et al., 2002). To determine whether
Figure 3B, lower panel). In further support of the inability
the H60 glycoprotein increases the generic sensitivity of
of H60 to induce immune responses autonomously, B6
TCR triggering, we compared the ability of Db-restricted
mice (n  10) showed no signs of rejecting tail skin
CTL lines (all of which express NKG2D as assessed by
allografts from sex-matched B6.C-H60-congenic mice,
RT-PCR; data not shown) to lyse H60-negative (B6) and
at least up to 100 days. H60 immunodominance was
H60-positive (H60-congenic) T cell lymphoblast target
therefore entirely dependent on help from a CD4 T cell
cells incubated with limiting concentrations of cognate
response generated by recognition of antigens on the
peptide ligands. Regardless of whether the target cells
same APC. Taken together, the results suggest that H60
were H60-positive or not, the peptide concentrations
immunodominance is independent of functions associ-
required to achieve specific cytolysis were virtually su-
ated with NKG2D engaging its H60 glycoprotein ligand.
perimposable (Figure 3A), indicating that physiological
expression of H60 does not reduce the threshold of TCR
triggering. H60 Immunodominance Occurs Even When There
Is No Competition In Vivo for Donor APCsNKG2D engagement converges with the CD28 signal-
ing cascade (Jamieson et al., 2002). H60 immunodomi- H60 immunodominance over other minor H antigens
could be determined by antigenic competition on APCs.nance might thus be a consequence of costimulatory
signals delivered to responding H60p-specific CD8 T To test this possibility, B6 female mice were immunized
with spleen cells from BALB.B male or with a mixturecells via NKG2D engagement with native H60 protein
on APCs. To test this possibility, we serially analyzed of splenocytes from B6 male, H13-congenic male, and
H60 Immunodominance
597
Figure 4. The anti-H60p Response Domi-
nates Regardless of Whether Antigens Are
Presented Separately or Together on Donor
APCs
(A) B6 mice were immunized with BALB.B
spleen cells or with mixture of H60-congenic
male, H13-congenic male, and B6 male
splenocytes (all induce CD4 help). PBLs
pooled from five immunized mice were
stained with H60p, H13p, and HYp tetramers.
(B) Pfp-deficient B6 mice were immunized
and analyzed in the same way.
H60-congenic male mice. (Male APCs were used to en- antigens on donor APCs. Thus, destruction by cytotoxic
effectors enhances H60 immunodominance, but not bysure a CD4 T cell stimulus.) As expected (Choi et al.,
2001), immunization of mice with BALB.B male cells a mechanism involving antigenic competition on APCs
resulted in a substantial expansion of H60p tetramer
CD8 T cells but not H13p or HYp tetramer cells (Figure
4A, left panel). Immunization with cells presenting the H60 Generates a Primary CTL Response In Vitro
While Other Minor H Antigens Do Notthree antigens separately reduced the level of H60 im-
munodominance only slightly in that a small but signifi- Conventional wisdom holds that it is not possible to
generate minor H antigen-specific CD8 T cells fromcant percentage of H13p tetramer cells was detected
(Figure 4A, right panel). These results suggested that mixed leukocyte culture (MLC) of naive T cells (Bevan,
1975; Gordon et al., 1975). To attempt to elicit specificH60 immunodominance was slightly relaxed when the
minor H antigens were presented on separate donor CD8 T cells from naive mice, responder spleen cells
from naive B6 female mice were cultured in primary (1)APCs, but not enough to account for the immunodomi-
nant H60 phenotype. MLC with irradiated stimulator spleen cells from H60-
congenic female, H13-congenic female, or B6 maleWe then examined whether prolonged survival of do-
nor APCs would influence the immunodominance hierar- mice. Eight days after 1 MLC (which included supple-
mentation with rIL-2 to insure help), 6% of the CD8 Tchy. Perforin-deficient (Pfp/) mice generated 2025-
fold reduced CTL activity against minor H antigens (data cells (range 612% in seven experiments) generated in
response to H60-congenic stimulators were H60p tetra-not shown), which should extend the survival of donor
APCs by reducing cytotoxic cell-mediated destruction. mer, while MLCs against H13 and HY stimulators
yielded insignificant frequencies of the respective tetra-Perforin-deficient B6 (B6-Pfp/) female mice immu-
nized with BALB.B male cells showed a slightly reduced mer cells (Figure 5A). Since in vitro stimulation of T
cells in IL-2 drives cell differentiation into short-livedmagnitude of their CD8 response to H60p, but there was
no concomitant increase in the H13p or HYp responses effector cells (Manjunath et al., 2001; Weninger et al.,
2001), we could not rule out the possibility that H13-(compare Figures 4A and 4B, left panels), indicating that
prolonged survival of donor APCs did not influence the and HY-specific CD8 T cells might have gone through
an undetected clonal burst followed by premature acti-dominance hierarchy. Moreover, the magnitude of the
H60 response was reduced 3-fold in B6-Pfp/ mice vation-induced cell death. Since IL-15 drives CD8 T cell
differentiation into the long-lived memory phenotype,immunized with a mixture of APCs presenting minor H
antigens separately as compared with B6-wild-type we therefore examined whether H60 would dominate
after 1 MLC supplemented with IL-15. Only H60p tetra-mice immunized with the same cells (Figures 4A and
4B, right panels), and the CD8 T cell responses against mer CD8 T cells were generated, although the percent-
age was reduced to2% (Figures 5B and 5C). Moreover,H13 and HY antigens were unchanged. These results
suggested that donor APC destruction by host cytolytic a high frequency of H60 tetramer CD8 T cells was also
observed after 1 MLC of naive CD4CD8-enrichedeffectors enhances H60 immunodominance, but it does
so more efficiently when there is no competition for thymocytes, indicating that H60 immunodominance was
Immunity
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Figure 5. H60 Is the Only Minor H Antigen
that Induces Specific T Cells In Vitro from the
Naive Pool
(A) Naive splenocytes of B6 female mice were
subjected to 1 MLCs with irradiated H60-
congenic female, H13-congenic female, or B6
male spleen cells. rIL-2 (50 U/ml) was in-
cluded at the initiation of culture and supple-
mented again on day 5. On day 8 of the cul-
ture, the CD8 T cells were assessed for H60p,
H13p, and HYp tetramer staining.
(B and C) Similar primary MLCs were har-
vested on day 4, washed, and split into cul-
tures containing rIL-15 (20 ng/ml) (B) or IL-2
(50 U/ml) for 4 additional days (compiled in [C]).
(D) CD8 T cell-enriched thymocytes and
splenocytes from naive B6 female mice were
cultured in MLC with H60-congenic stimula-
tors and tested as in (A) for H60 tetramer
staining. No significant H13 tetramer staining
was observed with parallel analysis with H13-
congenic stimulators (data not shown).
(E) CML analysis using cells from 1 MLC of
naive B6 splenocytes and irradiated stimula-
tors from various congenic mice. Target cells
were T2-Kb or T2-Db pulsed with the appro-
priate minor H antigen peptides. Only H60p
targets showed lysis above irrelevant pep-
tide-pulsed control values (data not shown).
a consequence of thymic selection rather than periph- mer staining and for specific cytolysis. Considerable
amplification of H60p tetramer staining CD8 T cells oc-eral expansion events (Figure 5D).
To determine whether a 1 MLC would lead to the curred at both physiological and superphysiological
peptide levels (Figure 6A). In contrast, H13p tetramergeneration of CTLs directed against minor H antigens,
including H4, H7, and H28, which, like H60, are consid- staining CD8 T cells showed minimal expansion and only
at superphysiological peptide levels, and no significantered immunodominant in certain experimental settings
(Eden et al., 1999; Malarkannan et al., 1998; Nevala and HYp tetramer staining cells were detected at any peptide
concentration tested. Specific cytolytic activity corre-Wettstein, 1996), we stimulated naive B6 female cells in
1MLC (with added rIL-2) in separate cultures with H60-, lated with the tetramer data (Figure 6B). Stimulation with
H60p, in the absence of the native H60 glycoprotein,H28-, H7-, H4-, or H13-congenic stimulator spleen cells
and assessed the specific lytic activity generated. Sub- was therefore sufficient to recapitulate the immuno-
dominance phenomenon. Moreover, H60 immunodomi-stantial lytic activity against H60p was generated by
stimulation with H60-congenic cells, while only residual, nance occurred even when the need for crosspresenta-
tion was obviated by direct peptide pulsing of naive B6nonspecific NK-like cytotoxicity was detected after
stimulation with cells from other minor H-congenic cells responder cells (Figure 6C), indicating that H60 immuno-
dominance was not dependent on crosspresentation.(Figure 5E). The combined results suggest that among
an array of minor H antigens, all of which were expressed
in MLC at physiological levels, H60 was the only one CD8 T Cells Respond to the H60 Minor H Peptide
with High Frequencycapable of generating appreciable numbers of CTLs in
vitro from the naive precursor pool. The ability of naive T cells to generate a response to
H60p in vitro led us to speculate that H60 immunodomi-To address whether H60 immunodominance of pri-
mary response was dependent on expression of the nance was a consequence of a high number of precursor
T cells. We were not able to detect a significant numbernative H60 glycoprotein, we cultured naive B6 female
cells in 1MLC with H60p-, H13p-, or HYp-pulsed irradi- of H60p tetramer CD8 T cells in lymphoid tissues from
naive mice (data not shown), suggesting that the fre-ated syngeneic spleen cells (Figure 6A). We then ana-
lyzed the resulting cultures several days later for tetra- quency of naive cells falls below flow cytometric resolu-
H60 Immunodominance
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Figure 6. The H60 Peptide Readily Induces
Specific CD8 T Cells from the Naive Pool
(A) Tetrameric analysis of naive female B6
splenocyte responder CD8 T cells after cul-
ture independently with syngeneic irradiated
splenocytes pulsed with various concentra-
tions of H60p, H13p, or HYp. Cultures were
supplemented with rIL-2.
(B) CML assay of effector cells from 104 and
106 M peptide doses from (A) against pep-
tide-loaded T2-Kb or T2-Db targets. Nonspe-
cific lysis against VSVp- or F5NPp-loaded T2
targets was subtracted.
(C) Tetrameric analysis of CD8 T cells from
cultures of naive female B6 splenocytes di-
rectly pulsed with H60p or H13p. Cultures
were supplemented with rIL-2.
tion. To determine their precursor frequencies, conven- and physiological expression of the native H60 glyco-
protein provided neither help nor other activation signalstional limiting dilution analysis was performed using B
and NK cell-depleted spleen cells from naive female B6 that supported CTL activation. Moreover, H60p in the
absence of the H60 glycoprotein was sufficient to reca-mice as responders and syngeneic spleen cells irradi-
ated and pulsed with H60p, H13p, or HYp as stimulator pitulate H60 immunodominance in vitro, suggesting that
it is an inherent property of the H60 peptide itself. Inter-cells. The minimal CTL precursor frequency (CTLpf) spe-
cifically reactive with H60p ranged between 1/11,140 to estingly, peptide blocking and mutation studies have
suggested that NKG2D interacts with the H60 glycopro-1/23,600 (four determinations), while the anti-H13p and
HYp CTLpfs were extrapolated to be at least 16-fold tein at a site that includes the immunodominant H60p
sequence (Cerwenka et al., 2002). However, consideringlower (two determinations) (Figures 7A and 7C). These
results suggested that precursor frequency is sufficient our inability to link the anti-H60p T cell response with
the native H60 glycoprotein, it is unclear how this obser-to explain H60 immunodominance. For comparison, the
H60p CTLpf was approximately 1020-fold lower than vation could explain our results. Thus, while there is
strong evidence supporting immune enhancing functionthat directed against H-2Kd alloantigens (1/8901/
1,500; Figures 7A and 7C). when H60 is overexpressed in tumor cells (Diefenbach
et al., 2000), we were unable to detect any role for theImportantly, the CTLpf dominant for the Kb-restricted
VSV peptide (Ono et al., 1998; Van Bleek and Nathenson, H60 protein other than to provide a processed minor H
peptide.1990) was only slightly lower compared with the anti-
H60p CTLpf (Figures 7B and 7C), indicating that immune Are there properties of the H60 minor H peptide and
its presentation on APCs that could engender immuno-responses against these two dominant antigens can be
induced at a similar intensity. To determine whether dominance? H60p is not unusual in its MHC binding
avidity, and the estimated number of H60p/Kb com-other dominant antigens induced high T cell precursor
frequency, we cultured naive B6 spleen cells with syn- plexes on tumor cells is between 5 and 15 copies/cell
(Malarkannan et al., 1998), values that are similar to orthetic immunogenic viral peptide epitopes, including
several known to immunodominate after viral infection less than those found for more subordinate minor H
(Belz et al., 2000). Epitope-specific CTLs were elicited epitopes (Eden et al., 1999; Mendoza et al., 1997).
in vitro from naive T cells stimulated with VSVp and PB1- Many explanations for immunodominance center
F262-70, but at reproducibly lower levels compared with around competition by T cells for their cognate ligands
H60. No activity was detected against the other epitopes on APCs (Grufman et al., 1999; Kedl et al., 2000, 2002;
(Figure 7D). This finding is consistent with a high fre- Perreault et al., 1998). Competition on donor cell APCs
quency of CTLp directed against H60p, VSVp, and PB1- played a negligible role in H60 immunodominance. How-
F262-70, but not against the other peptides tested, at least ever, accessibility of H60 to recipient APCs facilitated
under the experimental conditions used. the elaboration of H60p immunodominance in that MHC-
disparate BALB/c cells efficiently crossprimed mice for
an H60p-specific response, not for an HYp- or H13p-Discussion
specific response. Furthermore, Pfp-intact mice were
more efficiently primed to H60p than were Pfp-deficientOur studies show that the immune response directed
mice, suggesting that donor cell lysis may enhance theagainst H60 is atypical of minor H antigens in that it
supply of H60p to recipient APCs. These results indicatecompetes well with an allo-MHC response and induces
that crosspriming (Bevan, 1975) via indirect presentationnaive T cells to generate a potent CD8 T cell response
(Auchincloss and Sultan, 1996) operates efficiently forin vitro. The expression of H60 immunodominance was
entirely dependent on cognate help from CD4 T cells, H60p but not for minor H antigens such as HY (Millrain
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et al., 2001). However, it is unlikely that differential effi-
ciency of crosspriming is the explanation because H60
immmunodominance was recapitulated when naive re-
sponder cells were directly pulsed with minor H pep-
tides. More likely, the ability of H60 to be detected by
crosspriming is a manifestation of the overall magnitude
of the immune response against this antigen.
Our results suggest that H60 immunodominance is an
inherent property of the naive precursor pool. This is
manifested as an abnormally high frequency of H60p-
specific CD8 T cells, which enables naive T cells to
generate a robust T cell response in vitro. However,
bolstering the frequency of anti-H13 T cells by preimmu-
nization did not reverse H13’s subordinance to H60 (Choi
et al., 2001), indicating that numbers alone are not suffi-
cient to confer immunodominance. Quantitative and
qualitative variation in the naive precursor pool are likely
to be determined differences in the extent to which posi-
tive or negative thymic selection occurs (Correia-Neves
et al., 2001; Vidal et al., 1996). If self-peptides have
sufficient structural similarity to foreign peptides, they
could act as partial agonists during negative thymic
selection, thus reducing the size and avidity of the pre-
cursor pool and resulting in subordination of immune
response to the foreign epitope (Choi et al., 2001). The
great majority of identified autosomal and mitochon-
drally encoded minor H antigens arise as a consequence
of allelic variation within a self-MHC bound peptide and
thus have allelic partial agonists that are likely to nega-
tively select TCRs with high avidity for the foreign minor
H antigen counterpart. Human SMCY-encoded HY anti-
gens and mouse Smcy- and Uty-encoded HY antigens
possess highly sequence divergent “pseudoallelic”
Smcx and Utx X chromosome counterparts (Greenfield
et al., 1996; Meadows et al., 1997; Scott et al., 1995;
Wang et al., 1995); the human HY antigens are immuno-
dominant (Mutis et al., 1999), but for unknown reasons
the mouse HYs are not. H60, and H28, are immuno-
dominant and alloantigenic because B6 mice fail to ex-
press the H60 and H28 genes and thus lack any allelic
counterpart (Malarkannan et al., 2000, 1998). There is
an unusually high frequency of thymic and peripheral
CD8 precursor T cells specific for the dominant melan-
A/MART-1 tumor antigen (Pittet et al., 1999; Zippelius
et al., 2002). Melan-A/MART-1 expression is normally
limited to melanocytes (Pittet et al., 1999). The dominant
determined after subtraction of irrelevant target lysis are shown.
Indicated cognate targets (irrelevant targets): HYp-pulsed T2-Db
(F5NPp-pulsed T2-Db); H13p-pulsed T2-Db (F5NPp-pulsed T2-Db);
H60p-pulsed T2-Kb (VSVp-pulsed T2-Kb); P1.HTR (RMA); and VSVp-
pulsed T2-Kb (H60p-pulsed T2-Kb).
(C) Estimates of antigen-specific CTLpf for each mouse analyzed.
CTLpfs of anti-HYp and anti-H13p fell below the limit of resolution
of the assays (n  2, two determinations).
(D) Naive B6 mouse splenocytes were pulsed with the indicated
concentrations of synthetic peptides, cultured as in Figure 5C, and
Figure 7. CTLpf Analysis of Naive T Cells tested in a CML against T2-Kb and T2-Db targets pulsed with 100 nM
(A and B) Limiting numbers of B and NK cell-depleted spleen cells cognate and noncognate peptide. Values shown are the maximum
from naive B6 female mice were cultured in micro-MLC with spleno- mean lysis  SD at E/T 25:1 of target cells pulsed with the same
cytes loaded with 50 M of peptide or with allo-H-2Kd (B6-NOD- peptide used in the MLC minus lysis against targets pulsed with
H2g7) splenocytes. On day 7–8, each microwell was split and assayed the noncognate peptide. Others, maximum lysis after pulsing with
for cytolysis of the cognate target and an irrelevant control target. PA224-233, PB1703-711, PB2198-206, NS2114-121, M1128-135, or H13p. The data
Representative data of % specific cytolysis of individual microwells are representative of two independent experiments.
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CML AssayMAGE-A, BAGE, and GAGE antigens are normally ex-
A modified 51Cr release assay has been described (Roopenian etpressed only in testes germ cells (van der Bruggen,
al., 1983). For Concanavlin (Con A)-treated targets, splenocytes from2000). Immunodominance could therefore be dictated
various mice were cultured for 48 hr in the presence of Con A (100
by the extent to which their naive repertoire is unencum- g/ml). For peptide-loaded targets, 51Cr-labeled T2-Db and T2-Kb cells
bered by negative thymic selection. or syngeneic and congeneic splenocytes were incubated with 100
nM synthetic peptides for 30 min at 37C, washed twice with PBSHowever, it is perplexing that among an assortment
to remove unbound peptide, and then incubated at 37C with effectorof viral peptides tested, only the dominant VSVp epitope
cells in V-bottom plates at various E/T ratios. Lysis of target cellsand the subordinate epitope PB1-F261-70 evoked a robust
was measured as specific cytolysis, based on the level of 51Cr re-response from naive T cells (Figure 7E). While the posi-
leased into the supernatant relative to spontaneous and maximal
tive results with VSVp are consistent with a robust pre- 51Cr, and is reported as the mean of triplicate wells. Synthetic pep-
cursor repertoire, it is not known why reportedly domi- tides H60p LTFNYRNL, H13bp SSVIGVWYL, HYp Uty:WMHHNMDLI
(Greenfield et al., 1996), H28p ILENFPRL (Malarkannan et al., 2000),nant peptide epitopes, such as PA224-233 (Belz et al., 2000),
H4bp SGIVYIHL (S. Malarkannan and D.C.R., unpublished data), H7bprepeatedly failed to induce a primary response. Natively
KAPDNRDTL (S. Malarkannan and D.C.R., unpublished data), VSVpprocessed PB1-F261-70 is usually subdominant because
RGYVYQGL (Van Bleek and Nathenson, 1990), and F5Np366-374 AS-it is processed inefficiently by immunoproteasomes
NENMETM (Belz et al., 2000) were produced, chromatography-puri-
(Chen et al., 2001); our results suggest that its place in fied, and mass spectometry-verified by Research Genetics Inc.
the hierarchy shifts upward when its expression is not (Huntsville, AL). PA224-233 SSLENFRAYV, PB1-F262-70 LSLRNPILV,
PB1703-711 SSYRRPVGI, PB2198-206 ISPLMVAYM, NS2114-121 RTFSFQLI,constrained by inefficient antigen processing. Thus,
and M1128-135 MGLIYNRM were a kind gift of J. Yewdell (N.I.H.). H60p,while immunodominance is multifactoral (Yewdell and
H28p, VSVp, PB1703-711, NS2114-121, PB2198-206, and M1128-135 are Kb bind-Bennink, 1999), our overall studies document consider-
ing peptides. H13p, H4p, H7p, HYp, F5Np366-374, PA224-233, and PB1-able variation in the naive precursor repertoire and pre-
F262-70 are Db binding peptides.dict that this variation is an important first step in estab-
lishing the immunodominance hierarchy. Intracellular IFN- Assay
The alloantigenic complexity when tissues are trans- Modified intracellular IFN- staining analysis has been described
(Choi et al., 2001). In brief, cells from B6 anti-CB6F1 and anti-BALB.Bplanted between genetically nonidentical individuals
MLCs were harvested on d11 of MLC. One million responder cellshas the potential to be enormous, certainly much more
were then cultured with stimulator cells in 96-well round bottomthan immune responses to viruses and other more geno-
plates (Costar, Cambridge, MA) in DMEM (0.2 ml/well) for 2 hr. Themically constrained organisms. The fact that the B6 anti-
stimulators were RBC- and CD8-depleted splenocytes from various
H60p response prevails to the extent that it can account allogeneic and syngeneic mice. After 2 hr restimulation, brefeldin A
for almost 7% of the allogeneic CD8 T cell response to (Sigma, St. Louis, MO) was added to a final concentration of 10
g/ml and cells were incubated an additional 4 hr. The cells wereBALB/c alloantigens (Figure 2) is remarkable given that
then surface-stained with FITC-conjugated anti-CD8 mAb, washed,H60p is only one of potentially thousands of novel pep-
fixed with 1% paraformaldehyde in PBS, and then incubated withtides naturally presented by MHC proteins (Luckey et
PE-conjugated anti-IFN-mAb (PharMingen, San Diego, CA) dilutedal., 2001). Conversely, this high frequency also suggests
in 0.1% saponin (Sigma, St. Louis, MO) in PBS. The stained cells
that the diversity of the alloreactive T cell peptides func- were analyzed by flow cytometry with live cell gating.
tionally capable of inducing significant clonal bursts
might be much more limited than would be expected by Flow Cytometry and Cell Purification
RBC-lysed fresh PBLs from immunized mice or cells from MLC werepeptide diversity alone. From this enormous antigenic
incubated at 4C for 50 min in staining buffer (1 	 PBS with 0.1%complexity, H60 emerged as being superdominant. Un-
BSA and 0.1% sodium azide) containing PE-labeled H60p/Kb, H13bp/derstanding why has considerable implications for tis-
Db, and HY-Utyp/Db tetramers (Choi et al., 2001) and saturatingsue transplantation and vaccine design.
amounts of APC-conjugated anti-CD8 mAb (PharMingen) and FITC-
conjugated CD11a mAbs (M1/70; The Jackson Laboratory). The
Experimental Procedures stained cells were analyzed using a FACSCalibur equipped with
CellQuest software (Becton Dickinson, San Diego, CA). Thymic and
Mice, Immunization, and Skin Grafting spleen cells were negatively depleted of CD4 and B220 cells using
Standard C57BL/6J (B6), C.B10-H2b/LiMcdJ (BALB.B: H-2b), (B6/J magnetic bead separation methodology (Dynal Biotech, Oslo).
X BALB/cByJ) F1 (H-2bxd), B10.D2/SnJ (H-2d), B10.BR/SgSn (H-2k),
BALB/cByJ (H-2d), and B6-background Perforin-deficient (PfpTm1Sdz) MLC
mice were obtained from the JRS production facility of The Jackson For MLC of cells from naive female B6 mice, 2.5 	 107 responder
Laboratory. Congenic strains B6.C-H60c/Dcr (Choi et al., 2001), splenocytes were cultured with 3.5	 107 2000 cGY irradiated splen-
B10.CE-H13bAw(30NX)/Sn, B10.129-H46bH47b(21M)/Sn, B6.C-H28c/ ocytes from congenic mice or with B6 splenocytes loaded with
By, B10.C-H7c(47N)/Sn, and B6.NOD-H2g7 mice (kindly provided by H60p, H13p, or HYp. For peptide loading, unless otherwise indi-
David Serreze, The Jackson Laboratory) were bred and maintained cated, splenocytes were incubated with at 500 nM synthetic pep-
in The Jackson Laboratory Research Colonies. All mice were 8 to tides in medium for 30 min at 37C and washed twice with PBS to
14 weeks of age. For immunization, female B6 mice were injected remove unbound peptide. The MLCs were cultured in 10 ml of
intraperitoneally with 2 	 107 nonirradiated spleen cells. DMEM-5% FBS medium containing rIL-2 (50 U/ml) for 5 days and
fed with additional rIL-2 (50 U/ml), and harvested on d8 of culture.
MLC of cells from in vivo immunized mice was similar to that de-Cell Lines
scribed above except that rIL-2 (50 U/ml) was added after 2–3 daysTumor cell lines T2-Db, T2-Kb, RMA (H-2b), and P1.HTR (H-2d) were
of culture and the cells were harvested on d5–6.maintained in DMEM (Life Technologies, Grand Island, NY) supple-
mented with 5% FBS (Hyclone, Logan, UT). The H60b-specific H-2Kb-
restricted CTL line SP/H60, the H13b-specific H-2Db-restricted CTL Limiting Dilution and CML Assays
The limiting dilution assay is a modified version of that describedline SP/H13, and the HY (Uty)-specific H-2Db-restricted CTL clone
CTL-10 have been described (Choi et al., 2001). CTL lines were by MacDonald et al. (1980). Spleen cells from B6 female mice were
depleted of NK- and B cells using magnetic column and were usedmaintained by weekly restimulation with appropriate stimulator cells
and 50 U/ml of rIL-2 (Roopenian et al., 1983). as responder cells. Varying numbers of the depleted responder cells
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(32 microwells/responder cell concentration) were cultured for 5 plantation antigens in vivo: the H60 histocompatibility antigen
dominates over all others. J. Immunol. 166, 4370–4379.days in 96-well flat-bottomed microtiter plates (Costar Corp) in the
presence of 5 	 105 irradiated stimulator splenocytes in 0.2 ml of Correia-Neves, M., Mathis, D., and Benoist, C. (2001). A molecular
DMEM-10% FBS medium supplemented with rIL-2 (50 U/ml). B6 chart of thymocyte positive selection. Eur. J. Immunol. 31, 2583–
splenocyte stimulator cells were loaded with 50 M of H60p, H13p, 2592.
or HYp by incubation for 40 min at 37C, washed, and then irradiated
Diefenbach, A., Jamieson, A.M., Liu, S.D., Shastri, N., and Raulet,
with 2000 cGY. Irradiated allogeneic B6.NOD-H2g7 stimulator splen-
D.H. (2000). Ligands for the murine NKG2D receptor: expression
ocytes (disparate from B6 at H-2K) were used where indicated. On
by tumor cells and activation of NK cells and macrophages. Nat.
d5, each microculture was fed 50 l of fresh DMEM-FBS containing
Immunol. 1, 119–126.
rIL-2 (200 U/ml). After 4 additional days of culture, 100 l of each
Diefenbach, A., Jensen, E.R., Jamieson, A.M., and Raulet, D.H.microculture was transferred into two V-bottom microwells and as-
(2001). Rae1 and H60 ligands of the NKG2D receptor stimulate tu-sayed for cytolysis against cognate and irrelevant antigens. T2-Kb
mour immunity. Nature 413, 165–171.or T2-Db cells loaded with synthetic peptides (100 nM) or syngeneic
RMA or allogeneic P1.HTR target cells were added to effector cells Eden, P.A., Christianson, G.J., Fontaine, P., Wettstein, P.J., Perre-
to a final volume of 200 l/well. The plates were incubated for 6 hr ault, C., and Roopenian, D.C. (1999). Biochemical and immunoge-
at 37C, 125 l of supernatant was then harvested, and supernatant netic analysis of an immunodominant peptide (B6dom1) encoded
radioactivity was determined. Positive wells were defined as wells by the classical H7 minor histocompatibility locus. J. Immunol. 162,
whose 51Cr-release exceeded the mean spontaneous release (32 4502–4510.
replicates) by 
3 SD, after subtraction for nonspecific lysis 51Cr- Girardi, M., Oppenheim, D.E., Steele, C.R., Lewis, J.M., Glusac, E.,
release (targets loaded with irrelevant peptides or syngeneic tumor Filler, R., Hobby, P., Sutton, B., Tigelaar, R.E., and Hayday, A.C.
target cells). CTLpfs were calculated by linear regression and Pois- (2001). Regulation of cutaneous malignancy by  T cells. Science
son distribution X2 analysis according to Taswell (1984). 294, 605–609.
Gordon, R.D., Simpson, E., and Samelson, L.E. (1975). In vitro cell-
Acknowledgments mediated immune responses to the male specific (H-Y) antigen in
mice. J. Exp. Med. 142, 1108–1120.
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